塞拉斯特通过调节CERKL来诱导铁,从而产生抗胃癌效应

相关实验视频

Updated: May 17, 2025

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics

Published on: March 15, 2024

Chang Yang^1,2,3,4, Rui Xue^1,2,3,4, Chuling Qin^1,2,3,4

¹Department of Clinical Pharmacy, School of Pharmacy, Guilin Medical University, Guilin 541001, Guangxi, China.

The American journal of Chinese medicine

|May 15, 2025

概括

塞拉斯特是一种天然化合物,通过诱导细胞通过铁亡死亡来抑制胃癌的生长. 这通过降低CERKL的调节而发生,为胃癌提供了潜在的新疗法.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
自然产品化学化学

背景情况:

胃癌是一个重大的全球健康挑战.
塞拉斯特是一种天然化合物,具有抗瘤特性,但其在胃癌中的确切机制尚未完全理解.

研究的目的:

为了研究基底的分子机制 celastrol的抗瘤作用在胃癌.
探索塞拉斯特对胃癌细胞的细胞增殖,迁移和细胞死亡途径的影响.

主要方法:

细胞活力,增殖和迁移试验 (CCK8,殖民地形成,Transwell).
流细胞计用于检测活性氧物种 (ROS).
铁离子,甲 (MDA) 和谷氨 (GSH) 水平的生物化学测定.
对于与铁死相关的蛋白质 (GPX4,SLC7A11) 的西部斑.
进行PCR阵列和基因表达分析,以确定关键的调节因素.
在小鼠体内瘤异种移植模型.

主要成果:

塞拉斯特抑制了胃癌细胞的增殖和迁移.
塞拉斯特诱导了反应性氧物种 (ROS) 的产生,并促进了铁离子积累,这是铁亡的特征.
塞拉斯特降低了谷氨 (GSH) 水平,并抑制了关键的铁化蛋白 (GPX4,SLC7A11).
切拉斯特对CERKL的下调被确定为ferroptosis的关键调解者.
塞拉斯特在体内抑制了瘤生长,没有显著的毒性.

结论:

塞拉斯托尔通过CERKL调节的铁死来抑制胃癌的进展.
塞拉斯特通过向铁亡,显示出作为胃癌治疗剂的潜力.
对切拉斯特和铁亡途径的进一步研究可能会导致新的胃癌治疗方法.

关键词:

一个圈子,一个圆.塞拉斯特罗尔 (celastrol) 是一种铁化是铁化的一种.胃癌胃癌胃癌胃癌这是一个PCR阵列.

更多相关视频

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer

Published on: May 10, 2024

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells

Published on: January 18, 2017

相关概念视频

Inhibition of Cdk Activity

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...

Drugs that Stabilize Microtubules

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Cancer Prevention

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...